New Research Indicates Reducing Antibiotic Use Alone May Not Be Sufficient Against 'Superbugs'

Recent findings from the University of Bath reveal that simply prescribing fewer antibiotics might not effectively curb the rise of antimicrobial resistance (AMR), a growing global health threat. Despite efforts to decrease antibiotic prescriptions, the spread of resistant bacteria persists in the environment, emphasizing the need for comprehensive strategies.

The study, published in the Journal of Global Antimicrobial Resistance, examined wastewater samples from four treatment plants in southwest England over two years, including periods during the COVID-19 pandemic. Researchers analyzed the presence of antibiotic resistance genes and compared these data with antibiotic prescription rates during the same timeframe. Notably, even though antibiotic prescriptions and detected drug levels in wastewater declined in some seasons, the levels of resistance genes did not reflect this decrease, indicating ongoing resistance development.

A significant decline in antibiotics and resistance genes was observed during COVID-related lockdowns, attributable to reduced human activity and pathogen spread. However, as restrictions eased and social interactions resumed, both antibiotic use and resistance gene levels increased again, pointing to the complex dynamics of AMR transmission.

Professor Barbara Kasprzyk-Hordern, director of the university’s Center of Excellence in Water-Based Early-Warning Systems for Health Protection, explained that the environmental presence of resistance genes allows bacteria to transfer resistance between each other, complicating control efforts. She emphasized that focusing solely on reducing antibiotic usage is insufficient because environmental reservoirs of resistance persist and continue to evolve.

The researchers advocate for a 'One Health' approach, integrating human, animal, and environmental health policies to effectively combat AMR. They highlight the importance of wastewater-based epidemiology as a cost-effective tool for monitoring antibiotic use and resistance spread, providing real-time data that can inform targeted interventions.

This ongoing research will contribute to establishing a living laboratory in collaboration with industry and government agencies, aiming to better understand pathogen and resistance dynamics from early warning to health outcomes. The findings underscore the complexity of tackling AMR and the necessity for coordinated, multifaceted public health strategies.

For more information, visit: source.